KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 105 filers reported holding KURA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,000 | -76.9% | 469 | -52.4% | 0.00% | – |
| Q3 2022 | $26,000 | -3.7% | 986 | -32.7% | 0.00% | – |
| Q2 2022 | $27,000 | +12.5% | 1,464 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | +20.0% | 1,464 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -25.9% | 1,464 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -12.9% | 1,464 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | -24.4% | 1,464 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | -33.9% | 1,464 | -23.5% | 0.00% | – |
| Q4 2020 | $62,000 | +5.1% | 1,913 | 0.0% | 0.00% | – |
| Q3 2020 | $59,000 | +90.3% | 1,913 | 0.0% | 0.00% | – |
| Q2 2020 | $31,000 | +675.0% | 1,913 | +537.7% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -44.4% | 300 | -50.0% | 0.00% | – |
| Q4 2017 | $9,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |